GLP-1 medications like semaglutide (the active ingredient in Wegovy & Ozempic) can be powerful tools for improving insulin resistance and supporting weight loss in PCOS
Its effects on hair are comparable to Minoxidil in som e studies, though more researc h is needed for advanced hair loss
Additionally, its interaction with GLP-1 is unique, favoring a specific pathway that promotes insulin secretion without necessarily triggering all GLP-1 effects
In one study funded by Eli Lilly, people who took 4.5 mg of dulaglutide had more weight loss (about 10 lb) than those on 1.5 mg (a little less than 7 lb) after 36 weeks on the drug
Additional contributors may include a longer duration of obesity, older age, lower adherence to exercise, and possible behavioral factors in the T2DM population [46]
This premium active ingredient is produced by non-GMO fermentation of glucose